Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VRDN
#3856
Viridian Therapeutics, Inc. Common Stock
29.380
0
+2.98%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+2.98%
Mudança mensal
-12.59%
Mudança em 6 meses
+30.87%
Mudança anual
+30.87%
Fechamento anterior
28.530
0
Open
29.380
0
Bid
Ask
Low
29.380
0
High
29.380
0
Volume
105
Mercados
Ações
Cuidados de saúde
VRDN
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
7.23 M
25.91 M
42.9 M
62.77 M
81.48 M
102.21 M
—
Valuation ratios
Enterprise value
—
646.14 M
1.36 B
1.61 B
1.75 B
3.31 B
8.18 B
Price to earnings ratio
—
-2.97
-7.04
-4.21
0.05
0.07
0.14
Price to sales ratio
—
79.53
516.08
3 185.62
19.03
—
—
Price to cash flow ratio
—
4.32
9.75
5.43
0.02
0.03
0.09
Price to book ratio
—
4.37
3.62
4.25
0.01
0.01
0.03
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.84
-0.39
-0.3
-0.48
-0.36
0.38
-0.23
Return on equity %
-0.92
-0.42
-0.33
-0.54
-0.4
0.47
-0.24
Return on invested capital %
-15.85 K
-14.4 K
-16.57 K
-30.31 K
-32.85 K
30.88 K
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-10.51 K
-2 690.79
-7 579.23
-81.04 K
-99.02 K
512.91
-179.79 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-10.54 K
-2 680.16
-7 329.23
-75.71 K
-89.39 K
483.57
-163.9 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.14
14.68
12.93
18.26
15.43
12.65
54.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.01
0
0
0.09
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
-0.01
0.01
0.04
0.03
0.09
0.18
Long term debt to total equity ratio
0
-0.01
0.01
0.05
0.03
0.12
0.22
Per share metrics
Operating cash flow per share
—
-4.58
-2.92
-4.12
-775.13
1 009.69
-815.42
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
16.53
13.23
10.67
2 394.25
3 195.38
9 233.79
Net current asset value per share
—
16.79
13.44
10.87
2 463.85
3 266.74
9 722.97
Tangible book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
Working capital per share
—
15.65
12.4
10.27
2 304.12
3 008.48
8 975.44
Book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
Notícias
Stifel reafirma classificação das ações da Viridian Therapeutic
Stifel reiterates Viridian Therapeutic stock rating on BLA review
Jefferies eleva preço-alvo das ações da Viridian Therapeutic com avanço nos testes
Jefferies raises Viridian Therapeutic stock price target on trial progress
Evercore ISI reitera classificação de ações da Viridian Therapeutic com convicção nos dados
Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Lucro da Viridian Therapeutics veio abaixo das projeções por $0,10; receita menor do que estimativas
Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
BB Biotech apresenta lucro 660% maior em 2025, mas projeta cautela para 2026
Truist mantém recomendação de compra para Viridian Therapeutics antes de resultados de estudo